Rafael Holdings, Inc.
A healthcare holding company in Newark, New Jersey, Rafael Holdings backs early-stage drug and medical-device ventures, with its lead therapy Trappsol® Cyclo™ in late-stage trials for the rare Niemann-Pick type C1 disease and the FDA-cleared VECTR System for ligament-release surgery. It was spun off in 2018 from IDT Corporation, the telecom run by Howard Jonas. Its name comes from the Hebrew for "God heals" — fitting for a company built around medicines.
Granted 495.5K · Bought 13.08M
Granted 127.5K
Granted 140.0K
Granted 29.5K
Granted 94.6K
Granted 55.2K
Granted 27.7K
Granted 50.8K
Granted 50.0K
Granted 6.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Jonas Howard SExec Chairman, CEO & President, Director, 10% owner · 23 transactions | — | 14.99M | 495.5K | 13.08M | — |
| Conkling WilliamChief Executive Officer · 11 transactions | +5.2% | 564.5Kas of Mar 2025 | 127.5K | — | — |
| Polinsky DavidChief Financial Officer · 21 transactions | +128.7% | 299.1K | 140.0K | — | — |
| Sieger MarkusDirector · 2 transactions | — | 219.7K | 29.5K | — | — |
| Weiss Michael JDirector · 3 transactions | +199.9% | 141.9K | 94.6K | — | — |
| Greenberg Stephen MDirector · 2 transactions | +116.7% | 102.5Kas of Jan 2025 | 55.2K | — | — |
| McCamish Mark AnthonyDirector · 1 transaction | +84.9% | 60.2Kas of Jan 2024 | 27.7K | — | — |
| Stein Mark NDirector · 2 transactions | — | 50.8K | 50.8K | — | — |
| Goldberg JohnCHIEF MEDICAL OFFICER · 1 transaction | — | 50.0Kas of Jan 2025 | 50.0K | — | — |
| Grayson AlanDirector · 1 transaction | — | 6.6K | 6.6K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +13.08M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.